Antagonist Protocol in IVF

Woman's Health University Hospital, Egypt200 enrolled

Overview

The antagonist protocol in a novel method of stimulation in the in vitro fertilization (IVF) patients. It has been tried in poor responders, polycystic ovary (PCO) patients and normal females undergoing IVF. Can it be used with the same efficacy in all patients?

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

200

Conditions

Infertility

Interventions

Gonadotropins releasing hormone antagonistDRUG

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 44 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * age: 20- 44 years * Poor responder females according to Bologna criteria * Polycystic ovarian disease females according to Rotterdam criteria * Females with infertility causes other than poor responders, or PCO; male factor or tubal block Exclusion Criteria: * refusal to get enrolled in the study * cases of infertility due to severe male factor

Locations (1)

Kasr el aini hospital

Cairo, Cairo Governorate, Egypt

RECRUITING

Outcomes

Primary Outcomes

number of oocytes collected and fertilized

Time frame: 6 months

Central Contacts

Dina M Dakhly, MD

CONTACT

01003498919 dinadakhly@gmail.com

mohamed abdalla, MD

CONTACT

01001721206 mohamedhassan100@hotmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.